BIO Investor Forum panel breaks down when, what, and why of IPOs
Biotech firms weighing an initial public offering (IPO) must consider timing, interest in ...
Read More
BIF 2024: ‘The IRA really disrupted how we think’
The Inflation Reduction Act (IRA) has been top of mind for many in ...
Read More
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
Prescription drug coverage in Medicare will see sweeping changes – for both health ...
Read More
BIO Investor Forum opens with encouraging news on financing
The tide has been rising in biotech investment in 2024—though it has not ...
Read More
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?
There is a great degree of renewed optimism for drug development in the ...
Read More
How to follow the 2024 BIO Investor Forum in San Francisco
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) ...
Read More
EDITORS' CHOICE
BIO Investor Forum opens with encouraging news on financing
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in the ...
October 16, 2024
Read More
LATEST NEWS
BIO Events
BIO Investor Forum panel breaks down when, what, and why of IPOs
Biotech firms weighing an initial public offering (IPO) must consider timing, interest in their product, the macro environment—and whether they really need all the headaches, ...
October 17, 2024
BIO Events
BIF 2024: ‘The IRA really disrupted how we think’
The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the impending ...
October 16, 2024
BIO's View
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American seniors they serve – despite ...
October 16, 2024
BIO Events
BIO Investor Forum opens with encouraging news on financing
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in the ...
October 16, 2024
BIO Events
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?
There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from the ...
October 15, 2024
HEALTH
BIO Investor Forum panel breaks down when, what, and why of IPOs
October 17, 2024
BIF 2024: ‘The IRA really disrupted how we think’
October 16, 2024
How to follow the 2024 BIO Investor Forum in San Francisco
October 14, 2024
AMR continues to pose a global threat
October 10, 2024
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
What to know about BIO’s 7 Core Strategic Priorities
October 3, 2024
Senate Sustainable Aviation Caucus to back pro-SAF legislation
September 30, 2024
House members seek to block new wildlife refuge rules regarding GE crops
September 16, 2024
Climate Change
What to know about BIO’s 7 Core Strategic Priorities
October 3, 2024
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve ...
Read More
Senate Sustainable Aviation Caucus to back pro-SAF legislation
September 30, 2024
What to know about Valley fever vaccine development
September 9, 2024
USDA approves genetic trait that helps wheat handle drought
August 30, 2024
Federal Policy
BIF 2024: ‘The IRA really disrupted how we think’
October 16, 2024
Senate Sustainable Aviation Caucus to back pro-SAF legislation
September 30, 2024
State Policy
Virginia Gov. Youngkin named BIO’s Governor of the Year
September 23, 2024
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization ...
Read More
International
AMR continues to pose a global threat
October 10, 2024
BIO speaks on Capitol Hill about mpox preparedness
October 3, 2024
BIO travels to Taipei to co-host BIO Asia-Taiwan
August 8, 2024
Bio's View
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
October 16, 2024
Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American ...
Read More